The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis

Authors: Staropoli, Nicoletta, Ciliberto, Domenico, Luciano, Francesco, Napoli, Cristina, Costa, Martina, Rossini, Giacomo, Arbitrio, Mariamena, Labanca, Caterina, Riillo, Caterina, Del Giudice, Teresa, Crispino, Antonella, Salvino, Angela, Galvano, Antonio, Russo, Antonio, Tassone, Pierfrancesco, Tagliaferri, Pierosandro

Source: In Critical Reviews in Oncology / Hematology January 2024 193

Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity.

Authors: Staropoli, Nicoletta, Salvino, Angela, Falcone, Federica, Farenza, Valentina, Costa, Martina, Rossini, Giacomo, Manti, Francesco, Crispino, Antonella, Riillo, Caterina, Ciliberto, Domenico, Arbitrio, Mariamena, Tassone, Pierfrancesco, Tagliaferri, Pierosandro

Source: Frontiers in Oncology; 2023, p1-9, 9p

Subject Terms: ENDOMETRIAL cancer, LUNGS, NEOVASCULARIZATION inhibitors, PEMBROLIZUMAB